Verifiedmarketreports.com has announced the addition of the “Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Research Report” The report focuses on global major leading players with information such as company profiles, product picture and specification.
Pune, India -- (SBWIRE) -- 04/11/2019 -- Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.
Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.
Key players in details:
Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, Fluxion, Gilupi, Cynvenio and Others.
The global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is valued at 6420 million USD in 2018 and is expected to reach 21700 million USD by the end of 2024, growing at a CAGR of 22.5%, according to recent research.
For More information Register free sample copy of this report here:
Market is segmented on the basis Type, Application and Region:
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market segment by type: CellSearch, Others.
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Segment by Applications: Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment, Others.
Scope of the Report:
According to the research, the most potential market in the main countries of circulating tumor cells (CTCs) and cancer stem cells (CSCs) industry is China, determined by the rising level of medical care. Besides, South America, Asia-Pacific should also be focused by the investors. They are the potential consumers of circulating tumor cells (CTCs) and cancer stem cells (CSCs).
The CellSearch test is the only FDA-approved test for CTC assessment. For the moment, the products are not comprehensive, and technologies are not stable.
Morbidity and mortality rate of cancer is rising at a faster speed worldwide and thus prevention of cancer and cancer treatment is grabbing attention of cancer researchers globally. Stem cells and cell therapy have shown significant potential to treat cancer effectively.
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market report comprises key factor which can be useful for any new player in the industry. It is possible due to comparative analysis and overview that is provided in the report. By focusing on all the details in the report, it is more than enough for any newcomers entering the industry so that they can get a better knowledge and study the market before making any strategic decision.
To know more about this report:
Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share (%) and Growth Rate (%) of product in these regions, from 2017 to 2024 (forecast), covering United States, North America (Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa), RoW (Rest of World).
There are 15 Chapters to deeply display the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market:
Chapter 1, to describe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), with sales, revenue, and price of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), for each region, from 2013 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2019;
Chapter 12, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Avail Discount for this report at:
About Verified Market Reports
Verified Market Reports is part of the Verified Market Research which offers premium reports from over hundreds of top publishers worldwide. It has the most widespread collection of market research reports, analysis & forecast data for businesses and governments. We update and improve our repository routinely to deliver instant online access to the world's most comprehensive and current database of expert insights.
firstname.lastname@example.org | +1 (704) 266-3234